Company Research Report: Mecomed



Company Overview



  • Name: Mecomed

  • Mission: Mecomed serves as a unified voice for international manufacturers and partners, championing the advancement of medical science and education in the Middle East and Africa. The association focuses on enhancing access to reliable medical technology, promoting ethical business practices, setting regulatory standards, and improving the perception of medical technology.

  • Founded: 2009

  • Key People:

  • Rami Rajab, CEO

  • Maher ElHassan, Chairman, Vice President & General Manager, BD

  • Farah N. Hamdan, General Manager, Zimmer Biomet

  • Gamal Safwat, General Manager, Smith & Nephew

  • Hani Khasati, Regional Director, Abbott Diabetes Care

  • Majdi Younis, Regional Business Director, Medtronic

  • Mazen Takhah, Sr. Director Govt. Affairs & Policy, Johnson & Johnson

  • Qusai Al Sayyed, Managing Director, bioMérieux

  • Roula Y. Halabi, Senior Vice President, CooperSurgical

  • Tarek El Rahbani, Senior Regional Director, Boston Scientific

  • Inna Nadelwais, Executive Director

  • Rana Chalhoub, Director Regulatory Affairs

  • Headquarters: Dubai Healthcare City, Dubai

  • Number of Employees: 501-1,000 employees

  • Revenue: No information is available

  • Known For: Mecomed is recognized for being a key influencer in healthcare, promoting ethical business practices, advancing access to medical technology, and enhancing industry compliance across the Middle East and Africa.


Products



  • Products Offered: As a trade association, Mecomed does not directly offer products. Instead, it supports member companies within the medical technology industry by advocating for regulatory and market access improvements.

  • High Level Description: Mecomed focuses on industry advocacy, ethical business practices, regulatory affairs, compliance, and market access.

  • Key Features:

  • Facilitating access to cutting-edge medical technology.

  • Promoting sustainable and ethical healthcare practices.

  • Setting credible regulatory standards.

  • Enhancing industry compliance.


Recent Developments



  • Recent Developments: Mecomed has been actively engaging with key healthcare authorities, partners, and members across the Middle East, especially focusing on innovation in the MedTech industry.

  • New Products Launched: No information is available

  • New Features Added to Existing Products: No information is available

  • New Partnerships:

  • Launch of the Women in MedTech Network (WMN) to promote gender equality and leadership in the industry.

  • Co-organization of the 2025 MEA MedTech Regulatory Summit with the Regulatory Affairs Professionals Society (RAPS), to be held in January 2025 at voco Dubai.

  • Collaboration and active participation in various summits and workshops focused on medical technology and healthcare improvements in the MEA region.


This report provides a comprehensive overview of Mecomed, highlighting the most relevant and recent information about the company's market presence and strategic initiatives.